Abstract:Objectives To investigate the correlation between expression of FOXO3a and angiogenesis in breast invasive ductal carcinoma. Methods A total of 102 cases of breast invasive ductal carcinoma tissue (cancer group) and nearby normal tissue group (peri-carcinoma group) were involved in this study. Expression of FOXO3a was detected by immunohistochemistry. CD34 was stained as a marker of microvascular endothelial cells. Microvessel density (MVD) was evaluated and correlation between MVD and FOXO3a was analyzed. Results Expression of FOXO3a in breast cancer cells was significantly lower than that of peri-carcinoma group (70.59% vs 84.31%, P < 0.05). The positive rate of FOXO3a in nucleus of breast cancercells was decreased (15.69% vs 81.37%, P < 0.05) while that in cytoplasm increased dramatically (63.73% vs 14.71%, P < 0.05) compared with peri-carcinoma group. MVD in breast cancer tissues and cancer tissues with expression of FOXO3a in nucleus was upregulated obviously when compared with peri-carcinoma group and cancer tissues without expression of FOXO3a in nucleus, respectively [(27.46 ± 5.87 vs 17.25 ± 3.61, P < 0.05), (23.19 ± 4.00 vs 28.24 ± 5.84, P < 0.05), respectively]. MVD in cancer tissues with expression of FOXO3a in cytoplasm was not significantly different compared with that in cancer tissue cells without expression of FOXO3a in cytoplasm (26.39 ± 3.12 vs 27.90 ± 4.37, P > 0.05). Conclusion Expression of FOXO3a in nucleus of cancer tissue cells plays an important role in angiogenesis inhibition in breast invasive ductal carcinoma.